Capricor Therapeutics | CAPR - Cash And Equivalent


Capricor Therapeutics reported $44.28M in Cash and Equivalent for its fiscal quarter ending in September of 2026.





Cash And Equivalent Change Date
Alterity Therapeutics Limited AUD 15.77M 9.56M Jun/2023
Bioline Rx USD 4.63M 2.12M Jun/2026
Capricor Therapeutics USD 44.28M 23.34M Sep/2026
Cipla INR 16.59B 6.41B Sep/2026
Cytokinetics USD 203.43M 51.84M Sep/2026
Geron USD 69.18M 6.54M Sep/2026
Grifols EUR 979.78M 334.84M Dec/2024
Immunic USD 131.96M 23.14M Sep/2026
J&J USD 16.91B 3.51B Sep/2026
Plus Therapeutics USD 2.37M 656K Jun/2026
Prothena USD 271.37M 16.82M Sep/2026
PTC Therapeutics USD 508.89M 540.99M Sep/2026
Sarepta Therapeutics USD 472.76M 98.39M Sep/2026